Elanco CEO receives deferred stock unit grant
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc’s president, CEO and director Jeffrey N. Simmons received a grant of 113.8973 deferred stock units on July 10, 2026, referenced at $24.8200 per unit. Following this award, he holds 24,770.9021 deferred stock units directly.
Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment, or in a specified future year, under the Executive Deferral and Stock Match Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F2 | 113.8973 | $24.82 | $3K |
Footnotes (2)
- F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Key Figures
Key Terms
Deferred Stock Units financial
cash equivalent financial
Executive Deferral and Stock Match Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Elanco (ELAN) CEO Jeffrey N. Simmons report?
How many deferred stock units did Elanco (ELAN) grant to its CEO in this report?
What are deferred stock units in Elanco (ELAN)’s Executive Deferral and Stock Match Plan?
When will the Elanco (ELAN) deferred stock units reported by the CEO settle?
How many deferred stock units does Elanco (ELAN) CEO Jeffrey N. Simmons hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.